MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Forner, 2018, Hepatocellular carcinoma, Lancet, 391, 1301, 10.1016/S0140-6736(18)30010-2 H. Li and B.B. Yang, Friend or foe: the role of microRNA in chemotherapy resistance, Acta Pharmacol. Sin. 34 (7), 870-879. Li, 2018, Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling, Cell Cycle, 17, 2349, 10.1080/15384101.2018.1526599 Santasusagna, 2018, M, Monzo, Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients, Oncology, 95, 309, 10.1159/000490726 Feng, 2014, MiR-200, a new star miRNA in human cancer, Cancer Lett., 344, 166, 10.1016/j.canlet.2013.11.004 Cui, 2016, Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a, Oncotarget, 7, 65052, 10.18632/oncotarget.11350 Yu, 2017, Autophagy in the "inflammation-carcinogenesis" pathway of liver and HCC immunotherapy, Cancer Lett., 411, 82, 10.1016/j.canlet.2017.09.049 Hay, 2016, Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?, Na. Rev. Cancer, 16, 635, 10.1038/nrc.2016.77 Koppenhafer, 2018, mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells, Mol. Cancer Ther., 17, 2676, 10.1158/1535-7163.MCT-18-0260 Wong, 2018, OncomiR: an online resource for exploring pan-cancer microRNA dysregulation, Bioinformatics, 34, 713, 10.1093/bioinformatics/btx627 Saydam, 2009, Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway, Mol. Cell. Biol., 29, 5923, 10.1128/MCB.00332-09 Yao, 2018, TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition, J. Cell. Biochem., 119, 680, 10.1002/jcb.26231 Sherwood, 2014, WNT5A-mediated beta-catenin-independent signalling is a novel regulator of cancer cell metabolism, Carcinogenesis, 35, 784, 10.1093/carcin/bgt390 Yang, 2011, Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation, Nature, 480, 118, 10.1038/nature10598 Xie, 2016, Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics, Oncotarget, 7, 11609, 10.18632/oncotarget.7018 Araujo, 2018, Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma, Sci. Rep., 8, 14190, 10.1038/s41598-018-31170-6 Dodson, 2013, Cellular metabolic and autophagic pathways: traffic control by redox signaling, Free Radic. Biol. Med., 63, 207, 10.1016/j.freeradbiomed.2013.05.014 Lozy, 2012, F, V. Karantza, Autophagy and cancer cell metabolism, Semin. Cell Dev. Biol., 23, 395, 10.1016/j.semcdb.2012.01.005 Aravalli, 2013, Cellular and molecular mechanisms of hepatocellular carcinoma: an update, Arch. Toxicol., 87, 227, 10.1007/s00204-012-0931-2 Saito, 2014, A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma, Clin. Cancer Res., 20, 4784, 10.1158/1078-0432.CCR-14-1096 Xu, 2016, miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint, Nat. Commun., 7, 11406, 10.1038/ncomms11406 Meredith, 2016, Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism, J. Pharm. Pharmacol., 68, 729, 10.1111/jphp.12539 Lehwald, 2012, beta-Catenin regulates hepatic mitochondrial function and energy balance in mice, Gastroenterology, 143, 754, 10.1053/j.gastro.2012.05.048 Wong, 2015, PKM2 contributes to cancer metabolism, Cancer Lett., 356, 184, 10.1016/j.canlet.2014.01.031 Eriksson, 2017, Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism, Mol. Cell. Biol., 37, 10.1128/MCB.00328-17 Thomas, 2011, Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin, Mitochondrion, 11, 108, 10.1016/j.mito.2010.08.004 Sui, 2013, Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, Cell Death Dis., 4, 10.1038/cddis.2013.350 Zhang, 2018, Inhibition of the Wnt/beta-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer, Cancer Res., 78, 3147, 10.1158/0008-5472.CAN-17-3006 Uppada, 2018, MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/beta-catenin signaling, Mol.Cancer, 17, 111, 10.1186/s12943-018-0848-3 Renard, 2007, Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer, Cancer Res., 67, 901, 10.1158/0008-5472.CAN-06-2344 Xiao, 2013, microRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6, Oncol. Rep., 30, 2203, 10.3892/or.2013.2715 Chen, 2017, MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma, J. Cancer, 8, 617, 10.7150/jca.17394 Yang, 2015, MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2, Oncotarget, 6, 7918, 10.18632/oncotarget.3486 Vuppalanchi, 2013, Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis, PLoS One, 8, 10.1371/journal.pone.0074471 Gregory, 2011, An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition, Mol. Biol. Cell, 22, 1686, 10.1091/mbc.e11-02-0103 Sun, 2014, Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation, Mol. Cell. Biochem., 388, 11, 10.1007/s11010-013-1895-0 Koduru, 2018, Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs, Sci. Rep., 8, 7967, 10.1038/s41598-018-26360-1 Banerjee, 2016, Dysregulation of Wnt-Signaling and a Candidate Set of miRNAs Underlie the Effect of Metformin on Neural Crest Cell Development, Stem Cells, 34, 334, 10.1002/stem.2245 Cufi, 2012, Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205, Cell Cycle, 11, 1235, 10.4161/cc.11.6.19665